During the time of 2010 to 2015, export of medicines from Bangladesh to the outer world set a pleasant growth but during the last few months it began to deteriorate. The total export income during the last successive five years in serial are USD 40.96 million, 44.27million, 48.25 million, 59.82 million and 69.14 million. A growth of 15 to 20 percent was seen every year. Now the goal has been fixed at $73.02 million for FY’15.
However export of drugs and other pharmaceutical apparatus during last five months declined because of the commencement of the worldwide economical catastrophe. An official from Export Promotion Bureau stated that a fall of exports was last experienced in 2008-09 fiscal year because of the worldwide economic deterioration. During FY’09 exportation of pharmacy declined to $30.5 million though it was $33.0 million in the 2007-8 fiscal as per the official said.
Rabbur Reza, holding the chief operating officer’s position in Beximco Pharmaceutical Ltd stated that unfinished work of given orders and their supply must be the reason of deterioration of export. According to him, Myanmar, Sri Lanka and Kenya are the countries where the majority of medicines are exported though almost 50 countries bought pharmacy products from Bangladesh in a regular basis. Rabbur Reza is confident that this sector will make a comeback in a few months.
Md Shafiuzzaman who is the managing director at Hudson Pharmaceuticals Ltd., assumes that deterioration in exporting occurred because of some multinational companies who made the shipments to downturn.
As per his assumption pharmacy products are exported from the factories in Bangladesh to their mother companies by some of the MNCs. He also mentions that the continuation of political dilemma can also harm the all over exportation and make it fall.
Abul Muktadir, holding the post of Secretary at Bangladesh Association of Pharmaceutical Industries stated that exports of pharmacy products in the previous two months had been astounding and he can’t find any sense for the deterioration of export.
In the Asian region, Bangladesh leads to manufacture formulated goods in the midst of least developed countries. If the government of Bangladesh collaborates with the leading producers of pharmaceutical equipments and medicines, it would be easy to explore growing markets of African and European regions.
However export of drugs and other pharmaceutical apparatus during last five months declined because of the commencement of the worldwide economical catastrophe. An official from Export Promotion Bureau stated that a fall of exports was last experienced in 2008-09 fiscal year because of the worldwide economic deterioration. During FY’09 exportation of pharmacy declined to $30.5 million though it was $33.0 million in the 2007-8 fiscal as per the official said.
Rabbur Reza, holding the chief operating officer’s position in Beximco Pharmaceutical Ltd stated that unfinished work of given orders and their supply must be the reason of deterioration of export. According to him, Myanmar, Sri Lanka and Kenya are the countries where the majority of medicines are exported though almost 50 countries bought pharmacy products from Bangladesh in a regular basis. Rabbur Reza is confident that this sector will make a comeback in a few months.
Md Shafiuzzaman who is the managing director at Hudson Pharmaceuticals Ltd., assumes that deterioration in exporting occurred because of some multinational companies who made the shipments to downturn.
As per his assumption pharmacy products are exported from the factories in Bangladesh to their mother companies by some of the MNCs. He also mentions that the continuation of political dilemma can also harm the all over exportation and make it fall.
Abul Muktadir, holding the post of Secretary at Bangladesh Association of Pharmaceutical Industries stated that exports of pharmacy products in the previous two months had been astounding and he can’t find any sense for the deterioration of export.
In the Asian region, Bangladesh leads to manufacture formulated goods in the midst of least developed countries. If the government of Bangladesh collaborates with the leading producers of pharmaceutical equipments and medicines, it would be easy to explore growing markets of African and European regions.